Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
Phase 2
Recruiting
- Conditions
- Melanoma Stage IIIAdvanced MelanomaMelanomaMelanoma Stage IV
- Interventions
- First Posted Date
- 2024-03-06
- Last Posted Date
- 2025-03-12
- Target Recruit Count
- 90
- Registration Number
- NCT06295159
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Study of CG0070 After Transurethral Resection in Patients With IR NMIBC
- First Posted Date
- 2024-02-12
- Last Posted Date
- 2025-03-27
- Target Recruit Count
- 20
- Registration Number
- NCT06253845
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
Phase 1
Recruiting
- Conditions
- Breast CancerTriple Negative Breast Cancer
- Interventions
- First Posted Date
- 2024-02-02
- Last Posted Date
- 2025-05-09
- Target Recruit Count
- 31
- Registration Number
- NCT06238921
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC
Phase 1
Recruiting
- Conditions
- Squamous Cell Carcinoma of Head and NeckMetastatic Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2024-02-01
- Last Posted Date
- 2025-03-12
- Target Recruit Count
- 15
- Registration Number
- NCT06236425
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)
Early Phase 1
Recruiting
- Conditions
- Mycosis Fungoides
- Interventions
- Device: Phototherapy
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2025-02-13
- Target Recruit Count
- 20
- Registration Number
- NCT06235281
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)
Phase 1
Recruiting
- Conditions
- Lung CancerNon Small Cell Lung Cancer
- Interventions
- Drug: Difluoromethylornithine
- First Posted Date
- 2024-01-23
- Last Posted Date
- 2025-05-09
- Target Recruit Count
- 45
- Registration Number
- NCT06219174
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
REFLECT: Reproductive Education and Fertility Links for Cancer Treatment
Recruiting
- Conditions
- Reproductive Behavior
- Interventions
- Behavioral: REFLECT web-based tool
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2025-05-14
- Target Recruit Count
- 25
- Registration Number
- NCT06199726
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC
Phase 1
Recruiting
- Conditions
- Metastatic Castration-resistant Prostate Cancer
- Interventions
- First Posted Date
- 2024-01-05
- Last Posted Date
- 2025-03-27
- Target Recruit Count
- 30
- Registration Number
- NCT06193486
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Phase 2
Recruiting
- Conditions
- Acute Lymphoblastic LeukemiaB-Cell Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2023-11-22
- Last Posted Date
- 2025-04-18
- Target Recruit Count
- 60
- Registration Number
- NCT06144606
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Non-Invasive Biomarkers in Prostate Cancer Disease Management
Recruiting
- Conditions
- Prostate Cancer
- Interventions
- Genetic: Genomic and Histological Evaluation
- First Posted Date
- 2023-11-22
- Last Posted Date
- 2025-04-18
- Target Recruit Count
- 500
- Registration Number
- NCT06144619
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath